Gene Symbol | Gene ID | Gene Info |
---|---|---|
TEAD4
|
ENSG00000197905.4 | TEA domain transcription factor 4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_3067299_3067450 | TEAD4 | 1122 | 0.398388 | 0.36 | 3.5e-01 | Click! |
chr12_3067860_3068050 | TEAD4 | 541 | 0.694659 | 0.33 | 3.8e-01 | Click! |
chr12_3067581_3067732 | TEAD4 | 840 | 0.515005 | 0.32 | 4.1e-01 | Click! |
chr12_3068510_3068661 | TEAD4 | 5 | 0.968023 | -0.20 | 6.0e-01 | Click! |
chr12_3068772_3068976 | TEAD4 | 88 | 0.957802 | -0.15 | 6.9e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr12_91572648_91572799 | 0.85 |
DCN |
decorin |
394 |
0.91 |
chr6_148829356_148829537 | 0.72 |
ENSG00000223322 |
. |
15930 |
0.29 |
chr17_66950763_66951090 | 0.70 |
ABCA8 |
ATP-binding cassette, sub-family A (ABC1), member 8 |
456 |
0.87 |
chr4_55095719_55096018 | 0.60 |
PDGFRA |
platelet-derived growth factor receptor, alpha polypeptide |
142 |
0.98 |
chr6_80520238_80520389 | 0.56 |
ENSG00000221470 |
. |
16289 |
0.28 |
chr5_172753069_172753220 | 0.55 |
STC2 |
stanniocalcin 2 |
656 |
0.71 |
chr19_38129236_38129387 | 0.55 |
ZFP30 |
ZFP30 zinc finger protein |
16319 |
0.14 |
chr3_112356424_112356629 | 0.54 |
CCDC80 |
coiled-coil domain containing 80 |
418 |
0.88 |
chr12_91570174_91570436 | 0.53 |
DCN |
decorin |
2024 |
0.44 |
chr6_116832868_116833176 | 0.52 |
FAM26E |
family with sequence similarity 26, member E |
213 |
0.73 |
chr2_150982202_150982420 | 0.52 |
RND3 |
Rho family GTPase 3 |
359585 |
0.01 |
chr20_35170337_35170534 | 0.51 |
MYL9 |
myosin, light chain 9, regulatory |
535 |
0.71 |
chr3_29323785_29323954 | 0.51 |
RBMS3 |
RNA binding motif, single stranded interacting protein 3 |
762 |
0.71 |
chr1_85826475_85826626 | 0.50 |
DDAH1 |
dimethylarginine dimethylaminohydrolase 1 |
43630 |
0.13 |
chr6_28457374_28458144 | 0.50 |
GPX6 |
glutathione peroxidase 6 (olfactory) |
25805 |
0.14 |
chr4_24107639_24107790 | 0.50 |
PPARGC1A |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
216014 |
0.02 |
chr6_44509899_44510345 | 0.50 |
ENSG00000266619 |
. |
106744 |
0.06 |
chr12_124774068_124774247 | 0.49 |
FAM101A |
family with sequence similarity 101, member A |
447 |
0.88 |
chr6_39398889_39399040 | 0.49 |
KIF6 |
kinesin family member 6 |
125 |
0.98 |
chr7_19145980_19146451 | 0.48 |
AC003986.6 |
|
5882 |
0.17 |
chr10_4285370_4285529 | 0.48 |
ENSG00000207124 |
. |
271695 |
0.02 |
chr11_3403031_3403210 | 0.48 |
ZNF195 |
zinc finger protein 195 |
2672 |
0.22 |
chr10_129985700_129985940 | 0.48 |
MKI67 |
marker of proliferation Ki-67 |
61171 |
0.15 |
chr13_102105024_102105412 | 0.48 |
ITGBL1 |
integrin, beta-like 1 (with EGF-like repeat domains) |
200 |
0.96 |
chr16_65154468_65154619 | 0.47 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
1290 |
0.65 |
chr2_175187370_175187521 | 0.46 |
SP9 |
Sp9 transcription factor |
12229 |
0.16 |
chr17_42637074_42637426 | 0.46 |
FZD2 |
frizzled family receptor 2 |
2325 |
0.29 |
chr4_86700818_86700973 | 0.44 |
ARHGAP24 |
Rho GTPase activating protein 24 |
1036 |
0.65 |
chr10_63813819_63813970 | 0.44 |
ARID5B |
AT rich interactive domain 5B (MRF1-like) |
4924 |
0.3 |
chr10_14050350_14050950 | 0.44 |
FRMD4A |
FERM domain containing 4A |
118 |
0.97 |
chr3_114341689_114341840 | 0.43 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
1289 |
0.61 |
chrX_52862568_52862773 | 0.42 |
XAGE5 |
X antigen family, member 5 |
21079 |
0.15 |
chr1_86094618_86094769 | 0.42 |
ENSG00000199934 |
. |
36730 |
0.15 |
chrX_34672783_34673035 | 0.42 |
TMEM47 |
transmembrane protein 47 |
2496 |
0.45 |
chr15_49717369_49717525 | 0.42 |
FGF7 |
fibroblast growth factor 7 |
1990 |
0.39 |
chr2_175893407_175893558 | 0.42 |
ENSG00000199827 |
. |
1015 |
0.45 |
chr5_140857632_140858335 | 0.41 |
ENSG00000242020 |
. |
900 |
0.34 |
chr1_78441011_78441162 | 0.41 |
FUBP1 |
far upstream element (FUSE) binding protein 1 |
3659 |
0.19 |
chr21_17443452_17443630 | 0.41 |
ENSG00000252273 |
. |
35712 |
0.23 |
chr12_77309523_77309699 | 0.41 |
CSRP2 |
cysteine and glycine-rich protein 2 |
36771 |
0.18 |
chr21_17567832_17567983 | 0.41 |
ENSG00000201025 |
. |
89182 |
0.1 |
chr3_100711576_100712203 | 0.41 |
ABI3BP |
ABI family, member 3 (NESH) binding protein |
408 |
0.89 |
chr1_94078987_94079138 | 0.41 |
BCAR3 |
breast cancer anti-estrogen resistance 3 |
592 |
0.78 |
chr2_189847184_189847396 | 0.41 |
ENSG00000221502 |
. |
4472 |
0.25 |
chr22_28144536_28144687 | 0.41 |
RP11-375H17.1 |
|
32143 |
0.2 |
chr3_114169134_114169310 | 0.40 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
4308 |
0.3 |
chr1_164557864_164558015 | 0.40 |
PBX1 |
pre-B-cell leukemia homeobox 1 |
25897 |
0.21 |
chr5_159898024_159898392 | 0.40 |
ENSG00000265237 |
. |
3201 |
0.22 |
chr12_53985363_53985546 | 0.39 |
ATF7 |
activating transcription factor 7 |
9351 |
0.15 |
chr1_78884908_78885243 | 0.39 |
ENSG00000212308 |
. |
44122 |
0.17 |
chr13_74702709_74702889 | 0.39 |
KLF12 |
Kruppel-like factor 12 |
5595 |
0.34 |
chr1_17895906_17896057 | 0.39 |
ARHGEF10L |
Rho guanine nucleotide exchange factor (GEF) 10-like |
11067 |
0.26 |
chr13_108102804_108102955 | 0.39 |
ENSG00000221650 |
. |
80717 |
0.11 |
chr6_112192884_112193487 | 0.39 |
FYN |
FYN oncogene related to SRC, FGR, YES |
1055 |
0.66 |
chr3_20616495_20616647 | 0.39 |
ENSG00000206807 |
. |
67323 |
0.14 |
chr10_33240220_33240427 | 0.38 |
ITGB1 |
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
4268 |
0.33 |
chr2_204673173_204673324 | 0.38 |
ENSG00000206970 |
. |
26488 |
0.19 |
chr6_143168347_143168575 | 0.38 |
HIVEP2 |
human immunodeficiency virus type I enhancer binding protein 2 |
10277 |
0.28 |
chr8_41004141_41004292 | 0.38 |
ENSG00000206867 |
. |
113805 |
0.06 |
chr21_27042997_27043148 | 0.38 |
JAM2 |
junctional adhesion molecule 2 |
31162 |
0.16 |
chr6_24584146_24584297 | 0.37 |
KIAA0319 |
KIAA0319 |
61735 |
0.09 |
chr12_91448136_91448287 | 0.37 |
KERA |
keratocan |
3549 |
0.29 |
chr6_5498160_5498518 | 0.37 |
RP1-232P20.1 |
|
40031 |
0.2 |
chr1_221165183_221165334 | 0.37 |
HLX |
H2.0-like homeobox |
110674 |
0.06 |
chr12_22093789_22093940 | 0.37 |
ABCC9 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
303 |
0.94 |
chr21_28214648_28215240 | 0.37 |
ADAMTS1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
393 |
0.9 |
chr22_19931502_19931653 | 0.37 |
TXNRD2 |
thioredoxin reductase 2 |
2244 |
0.19 |
chr9_35276443_35276716 | 0.36 |
AL160274.1 |
HCG17281; PRO0038; Uncharacterized protein |
84683 |
0.07 |
chr10_79151412_79151734 | 0.36 |
KCNMA1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
12169 |
0.24 |
chr16_87414863_87415370 | 0.36 |
FBXO31 |
F-box protein 31 |
2247 |
0.19 |
chr21_17584847_17584998 | 0.36 |
ENSG00000201025 |
. |
72167 |
0.13 |
chr2_83792651_83792802 | 0.36 |
ENSG00000199295 |
. |
92133 |
0.1 |
chr8_49014264_49014415 | 0.36 |
UBE2V2 |
ubiquitin-conjugating enzyme E2 variant 2 |
60032 |
0.14 |
chr4_189776276_189776436 | 0.36 |
ENSG00000252275 |
. |
138477 |
0.05 |
chr18_13279449_13279641 | 0.36 |
LDLRAD4 |
low density lipoprotein receptor class A domain containing 4 |
1443 |
0.44 |
chr5_65124568_65124720 | 0.36 |
NLN |
neurolysin (metallopeptidase M3 family) |
40454 |
0.17 |
chr3_167784999_167785150 | 0.35 |
GOLIM4 |
golgi integral membrane protein 4 |
28058 |
0.26 |
chr20_439845_439996 | 0.35 |
TBC1D20 |
TBC1 domain family, member 20 |
3277 |
0.21 |
chr7_15597655_15597806 | 0.35 |
AGMO |
alkylglycerol monooxygenase |
3910 |
0.36 |
chr13_45145551_45145847 | 0.35 |
TSC22D1 |
TSC22 domain family, member 1 |
4693 |
0.31 |
chr14_73357781_73357932 | 0.35 |
DPF3 |
D4, zinc and double PHD fingers, family 3 |
2940 |
0.24 |
chr9_20605014_20605308 | 0.35 |
MLLT3 |
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 |
16711 |
0.19 |
chr17_59479149_59479300 | 0.35 |
RP11-332H18.5 |
|
1620 |
0.23 |
chr8_123101238_123101389 | 0.35 |
HAS2-AS1 |
HAS2 antisense RNA 1 |
447637 |
0.01 |
chrX_139585587_139585739 | 0.35 |
SOX3 |
SRY (sex determining region Y)-box 3 |
1562 |
0.53 |
chr10_14049890_14050132 | 0.35 |
FRMD4A |
FERM domain containing 4A |
521 |
0.82 |
chr4_15329290_15329441 | 0.35 |
C1QTNF7 |
C1q and tumor necrosis factor related protein 7 |
12077 |
0.26 |
chr11_14379258_14380093 | 0.35 |
RRAS2 |
related RAS viral (r-ras) oncogene homolog 2 |
356 |
0.92 |
chr1_240501387_240501653 | 0.35 |
ENSG00000252317 |
. |
3165 |
0.32 |
chr10_65520225_65520376 | 0.35 |
REEP3 |
receptor accessory protein 3 |
239177 |
0.02 |
chr12_88971091_88971358 | 0.34 |
KITLG |
KIT ligand |
3014 |
0.3 |
chr5_98118929_98119080 | 0.34 |
RGMB |
repulsive guidance molecule family member b |
9665 |
0.22 |
chr5_15500949_15501183 | 0.34 |
FBXL7 |
F-box and leucine-rich repeat protein 7 |
481 |
0.89 |
chr11_132863892_132864419 | 0.34 |
OPCML |
opioid binding protein/cell adhesion molecule-like |
50492 |
0.18 |
chr4_7937771_7938061 | 0.34 |
AC097381.1 |
|
2812 |
0.26 |
chr1_119589529_119589758 | 0.34 |
WARS2-IT1 |
WARS2 intronic transcript 1 (non-protein coding) |
385 |
0.9 |
chr11_12436083_12436234 | 0.34 |
PARVA |
parvin, alpha |
16370 |
0.24 |
chr1_193152641_193152821 | 0.34 |
B3GALT2 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 |
3053 |
0.27 |
chr12_26163834_26163985 | 0.34 |
RASSF8 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 8 |
760 |
0.72 |
chr17_2118811_2119625 | 0.34 |
AC130689.5 |
|
91 |
0.93 |
chr5_9698511_9698662 | 0.34 |
TAS2R1 |
taste receptor, type 2, member 1 |
13726 |
0.22 |
chr3_87036535_87037613 | 0.34 |
VGLL3 |
vestigial like 3 (Drosophila) |
2778 |
0.42 |
chr3_66350036_66350187 | 0.34 |
ENSG00000206759 |
. |
6467 |
0.24 |
chr16_79802458_79802717 | 0.34 |
ENSG00000221330 |
. |
98953 |
0.09 |
chr15_96885598_96885825 | 0.34 |
ENSG00000222651 |
. |
9221 |
0.16 |
chr6_26987323_26987625 | 0.33 |
ENSG00000238621 |
. |
640 |
0.74 |
chr15_99864560_99864718 | 0.33 |
AC022819.2 |
Uncharacterized protein |
4811 |
0.23 |
chr10_71950501_71950732 | 0.33 |
SAR1A |
SAR1 homolog A (S. cerevisiae) |
20337 |
0.17 |
chr9_75688893_75689044 | 0.33 |
ALDH1A1 |
aldehyde dehydrogenase 1 family, member A1 |
6390 |
0.31 |
chr7_42267308_42267709 | 0.33 |
GLI3 |
GLI family zinc finger 3 |
188 |
0.97 |
chr6_11394166_11394363 | 0.33 |
NEDD9 |
neural precursor cell expressed, developmentally down-regulated 9 |
11683 |
0.27 |
chr12_56329135_56329873 | 0.33 |
DGKA |
diacylglycerol kinase, alpha 80kDa |
114 |
0.92 |
chr6_118872690_118872841 | 0.33 |
PLN |
phospholamban |
3304 |
0.38 |
chr10_14052381_14052532 | 0.33 |
FRMD4A |
FERM domain containing 4A |
1924 |
0.38 |
chr19_19510958_19511314 | 0.33 |
CTB-184G21.3 |
|
2276 |
0.22 |
chr3_16217443_16217716 | 0.33 |
GALNT15 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15 |
1363 |
0.53 |
chr1_119589857_119590031 | 0.33 |
WARS2-IT1 |
WARS2 intronic transcript 1 (non-protein coding) |
84 |
0.98 |
chr3_164911903_164912054 | 0.33 |
SLITRK3 |
SLIT and NTRK-like family, member 3 |
1812 |
0.49 |
chr12_32261770_32262117 | 0.33 |
RP11-843B15.2 |
|
1481 |
0.38 |
chr8_91895980_91896131 | 0.32 |
RP11-662G23.1 |
|
24587 |
0.19 |
chr21_17796711_17796936 | 0.32 |
ENSG00000207638 |
. |
114586 |
0.06 |
chr3_11550824_11550978 | 0.32 |
VGLL4 |
vestigial like 4 (Drosophila) |
59497 |
0.14 |
chr11_75378366_75379067 | 0.32 |
MAP6 |
microtubule-associated protein 6 |
763 |
0.58 |
chr11_15962669_15962820 | 0.32 |
CTD-3096P4.1 |
|
81992 |
0.11 |
chr9_99214684_99214835 | 0.32 |
HABP4 |
hyaluronan binding protein 4 |
2272 |
0.34 |
chr14_100434757_100434946 | 0.32 |
EVL |
Enah/Vasp-like |
2935 |
0.26 |
chr1_64241295_64241446 | 0.32 |
ROR1 |
receptor tyrosine kinase-like orphan receptor 1 |
1656 |
0.5 |
chr3_157157240_157157391 | 0.32 |
PTX3 |
pentraxin 3, long |
2737 |
0.35 |
chr14_64375063_64375214 | 0.32 |
SYNE2 |
spectrin repeat containing, nuclear envelope 2 |
678 |
0.77 |
chr5_159510080_159510300 | 0.32 |
PWWP2A |
PWWP domain containing 2A |
36239 |
0.14 |
chr21_17790702_17790950 | 0.32 |
ENSG00000207638 |
. |
120583 |
0.06 |
chr7_556342_556585 | 0.32 |
PDGFA |
platelet-derived growth factor alpha polypeptide |
1682 |
0.39 |
chr5_112020339_112020490 | 0.32 |
APC |
adenomatous polyposis coli |
22781 |
0.23 |
chr14_55239474_55239625 | 0.32 |
SAMD4A |
sterile alpha motif domain containing 4A |
17998 |
0.24 |
chrX_138774922_138775171 | 0.32 |
MCF2 |
MCF.2 cell line derived transforming sequence |
731 |
0.69 |
chr20_22777018_22777212 | 0.32 |
ENSG00000265151 |
. |
63176 |
0.14 |
chr9_96819103_96819334 | 0.31 |
PTPDC1 |
protein tyrosine phosphatase domain containing 1 |
26142 |
0.21 |
chr10_69869590_69869741 | 0.31 |
MYPN |
myopalladin |
412 |
0.85 |
chr16_27005073_27005435 | 0.31 |
RP11-673P17.2 |
|
73925 |
0.12 |
chr14_53268449_53268728 | 0.31 |
GNPNAT1 |
glucosamine-phosphate N-acetyltransferase 1 |
10202 |
0.16 |
chr22_47241159_47241311 | 0.31 |
ENSG00000221672 |
. |
2568 |
0.36 |
chr3_158457850_158458001 | 0.31 |
RP11-379F4.4 |
|
281 |
0.88 |
chr7_19308836_19308987 | 0.31 |
FERD3L |
Fer3-like bHLH transcription factor |
123867 |
0.05 |
chr2_193015209_193015360 | 0.31 |
TMEFF2 |
transmembrane protein with EGF-like and two follistatin-like domains 2 |
43966 |
0.2 |
chr2_63990763_63990914 | 0.31 |
ENSG00000221085 |
. |
68169 |
0.11 |
chr2_30456555_30456706 | 0.31 |
LBH |
limb bud and heart development |
1584 |
0.45 |
chr11_39182817_39182968 | 0.31 |
ENSG00000201591 |
. |
99765 |
0.09 |
chr6_26342303_26342467 | 0.31 |
ENSG00000252399 |
. |
10879 |
0.09 |
chr5_42532028_42532179 | 0.31 |
GHR |
growth hormone receptor |
33855 |
0.24 |
chr3_29377379_29377667 | 0.31 |
ENSG00000216169 |
. |
33389 |
0.18 |
chr1_172327450_172327703 | 0.31 |
ENSG00000206684 |
. |
8104 |
0.18 |
chr1_196621837_196622284 | 0.31 |
CFH |
complement factor H |
874 |
0.67 |
chr6_23003728_23003960 | 0.31 |
ENSG00000207394 |
. |
121471 |
0.07 |
chr13_30276703_30277107 | 0.30 |
SLC7A1 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
107080 |
0.07 |
chr5_168839841_168839992 | 0.30 |
SLIT3 |
slit homolog 3 (Drosophila) |
111783 |
0.06 |
chr17_48858634_48858982 | 0.30 |
LUC7L3 |
LUC7-like 3 (S. cerevisiae) |
34828 |
0.11 |
chr7_90794067_90794435 | 0.30 |
FZD1 |
frizzled family receptor 1 |
99532 |
0.09 |
chr3_188840890_188841041 | 0.30 |
TPRG1 |
tumor protein p63 regulated 1 |
23055 |
0.27 |
chr10_24498389_24498682 | 0.30 |
KIAA1217 |
KIAA1217 |
433 |
0.9 |
chr4_71587677_71588145 | 0.30 |
RUFY3 |
RUN and FYVE domain containing 3 |
183 |
0.92 |
chr16_54969072_54969449 | 0.30 |
IRX5 |
iroquois homeobox 5 |
3276 |
0.4 |
chr13_76444739_76444999 | 0.30 |
C13orf45 |
chromosome 13 open reading frame 45 |
318 |
0.9 |
chr19_16493261_16493427 | 0.30 |
ENSG00000243745 |
. |
16426 |
0.13 |
chr9_102130669_102130820 | 0.30 |
ENSG00000222337 |
. |
84440 |
0.09 |
chr10_30981387_30981538 | 0.30 |
SVILP1 |
supervillin pseudogene 1 |
3388 |
0.32 |
chr16_48478898_48479145 | 0.30 |
RP11-44I10.6 |
|
3288 |
0.21 |
chr6_121869662_121869813 | 0.30 |
ENSG00000201379 |
. |
5965 |
0.25 |
chr17_750320_750517 | 0.30 |
NXN |
nucleoredoxin |
16919 |
0.14 |
chr13_94186434_94186585 | 0.30 |
ENSG00000252365 |
. |
165296 |
0.04 |
chr18_43169182_43169490 | 0.30 |
SLC14A2 |
solute carrier family 14 (urea transporter), member 2 |
25430 |
0.19 |
chr12_125170011_125170375 | 0.29 |
NCOR2 |
nuclear receptor corepressor 2 |
118183 |
0.06 |
chr2_182182084_182182235 | 0.29 |
ENSG00000266705 |
. |
11780 |
0.3 |
chr14_52328782_52328973 | 0.29 |
GNG2 |
guanine nucleotide binding protein (G protein), gamma 2 |
835 |
0.65 |
chr6_148842248_148842399 | 0.29 |
ENSG00000223322 |
. |
3053 |
0.4 |
chr3_15724598_15724749 | 0.29 |
ENSG00000264354 |
. |
14205 |
0.18 |
chr7_19135945_19136096 | 0.29 |
AC003986.6 |
|
16077 |
0.16 |
chr6_39850892_39851043 | 0.29 |
RP11-61I13.3 |
|
3377 |
0.29 |
chr10_133793669_133793880 | 0.29 |
BNIP3 |
BCL2/adenovirus E1B 19kDa interacting protein 3 |
1653 |
0.46 |
chr2_44404368_44404519 | 0.29 |
PPM1B |
protein phosphatase, Mg2+/Mn2+ dependent, 1B |
8394 |
0.18 |
chr12_112860465_112860616 | 0.29 |
PTPN11 |
protein tyrosine phosphatase, non-receptor type 11 |
3822 |
0.22 |
chr20_43211444_43211668 | 0.29 |
PKIG |
protein kinase (cAMP-dependent, catalytic) inhibitor gamma |
366 |
0.85 |
chr1_161129281_161130077 | 0.29 |
USP21 |
ubiquitin specific peptidase 21 |
352 |
0.52 |
chr6_20497460_20497742 | 0.29 |
ENSG00000201683 |
. |
2805 |
0.26 |
chr12_118626563_118627015 | 0.29 |
TAOK3 |
TAO kinase 3 |
1538 |
0.42 |
chr8_116672519_116672670 | 0.29 |
TRPS1 |
trichorhinophalangeal syndrome I |
1311 |
0.63 |
chr5_71544123_71544318 | 0.29 |
ENSG00000244748 |
. |
66295 |
0.09 |
chr7_47662641_47662792 | 0.29 |
C7orf65 |
chromosome 7 open reading frame 65 |
32126 |
0.2 |
chr12_18449386_18449629 | 0.29 |
PIK3C2G |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma |
14529 |
0.31 |
chr17_65474283_65474491 | 0.29 |
ENSG00000207688 |
. |
6782 |
0.16 |
chr7_17344121_17344405 | 0.29 |
AC003075.4 |
|
5282 |
0.24 |
chr17_2142192_2142344 | 0.28 |
SMG6 |
SMG6 nonsense mediated mRNA decay factor |
1217 |
0.33 |
chr4_170175719_170175897 | 0.28 |
SH3RF1 |
SH3 domain containing ring finger 1 |
15300 |
0.25 |
chr14_54686717_54686976 | 0.28 |
CDKN3 |
cyclin-dependent kinase inhibitor 3 |
176827 |
0.03 |
chr10_3570320_3570471 | 0.28 |
RP11-184A2.3 |
|
222864 |
0.02 |
chr3_143528390_143528541 | 0.28 |
SLC9A9 |
solute carrier family 9, subfamily A (NHE9, cation proton antiporter 9), member 9 |
38835 |
0.22 |
chr11_35413519_35413670 | 0.28 |
RP4-683L5.1 |
|
27010 |
0.18 |
chr17_55655032_55655337 | 0.28 |
RP11-118E18.4 |
|
30589 |
0.16 |
chr4_77356777_77357012 | 0.28 |
SHROOM3 |
shroom family member 3 |
641 |
0.68 |
chr7_45959503_45959698 | 0.28 |
IGFBP3 |
insulin-like growth factor binding protein 3 |
1250 |
0.48 |
chr16_8894210_8894380 | 0.28 |
PMM2 |
phosphomannomutase 2 |
2571 |
0.2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.4 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.1 | 0.9 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.4 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.1 | GO:0046449 | allantoin metabolic process(GO:0000255) creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.1 | 0.2 | GO:0019049 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.1 | 0.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.3 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.3 | GO:0010716 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.3 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.1 | 0.3 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 0.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.2 | GO:1904238 | mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) pericyte cell differentiation(GO:1904238) |
0.1 | 0.3 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.4 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.2 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.3 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
0.1 | 0.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.2 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.1 | 0.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.1 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 0.3 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.1 | GO:0070091 | glucagon secretion(GO:0070091) |
0.1 | 0.3 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.1 | 0.2 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.1 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.1 | 0.5 | GO:0061384 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.1 | 0.2 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.1 | 0.2 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.2 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.3 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.3 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.5 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.2 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.2 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.1 | 0.2 | GO:0034393 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.7 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.1 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 0.3 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.1 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.2 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.2 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.1 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.1 | 0.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.2 | GO:0060596 | mammary placode formation(GO:0060596) |
0.1 | 0.8 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.1 | 0.2 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 0.2 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 0.3 | GO:0043206 | extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
0.0 | 0.2 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.2 | GO:0007619 | courtship behavior(GO:0007619) |
0.0 | 0.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.0 | 0.1 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.0 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.2 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.0 | 0.1 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.1 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.0 | 0.2 | GO:0002857 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.0 | 0.1 | GO:0060242 | contact inhibition(GO:0060242) |
0.0 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.1 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.0 | 0.2 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.0 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.1 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.0 | 1.0 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.1 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.0 | 0.2 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.0 | 0.7 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.3 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.2 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.1 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.3 | GO:0006853 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
0.0 | 0.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.0 | 0.1 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.0 | 0.1 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.0 | 0.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.1 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.1 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 | 0.1 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.1 | GO:0070295 | renal water absorption(GO:0070295) |
0.0 | 0.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.0 | 0.4 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.0 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.0 | 0.2 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.0 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.0 | 0.1 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.0 | 0.1 | GO:2000144 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.1 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.0 | 0.0 | GO:0060435 | bronchiole development(GO:0060435) |
0.0 | 0.1 | GO:0019985 | translesion synthesis(GO:0019985) |
0.0 | 0.1 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.0 | 0.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.2 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.2 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.0 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.1 | GO:0003078 | obsolete regulation of natriuresis(GO:0003078) |
0.0 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.3 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.1 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.0 | 0.0 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.2 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.3 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.0 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.0 | 0.1 | GO:0006573 | valine metabolic process(GO:0006573) |
0.0 | 0.1 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) pattern specification involved in metanephros development(GO:0072268) |
0.0 | 0.1 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.0 | 0.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.3 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.2 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.0 | 0.1 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.0 | 0.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.0 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.1 | GO:0070828 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.0 | 0.2 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) myoblast fusion(GO:0007520) |
0.0 | 0.1 | GO:0060033 | Mullerian duct regression(GO:0001880) anatomical structure regression(GO:0060033) |
0.0 | 0.0 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.0 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.1 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.0 | 0.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.2 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.0 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.1 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.1 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.1 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.0 | GO:0097576 | vacuole fusion(GO:0097576) |
0.0 | 0.1 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.2 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.0 | 0.1 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.3 | GO:0001893 | maternal placenta development(GO:0001893) |
0.0 | 0.0 | GO:0072070 | loop of Henle development(GO:0072070) |
0.0 | 0.0 | GO:0031579 | membrane raft organization(GO:0031579) |
0.0 | 0.0 | GO:0032825 | natural killer cell differentiation(GO:0001779) regulation of natural killer cell differentiation(GO:0032823) positive regulation of natural killer cell differentiation(GO:0032825) |
0.0 | 0.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.1 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.0 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.0 | 0.1 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.0 | 0.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.4 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.0 | 0.1 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.0 | 0.0 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.1 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.1 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.1 | GO:1904035 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.0 | 0.1 | GO:0045822 | negative regulation of heart contraction(GO:0045822) |
0.0 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.1 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.0 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.1 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.0 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 0.1 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.0 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.0 | 0.2 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.0 | GO:0010665 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.0 | 0.1 | GO:0090399 | replicative senescence(GO:0090399) |
0.0 | 0.1 | GO:0045920 | negative regulation of exocytosis(GO:0045920) |
0.0 | 0.0 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 0.0 | GO:0009414 | response to water deprivation(GO:0009414) |
0.0 | 0.0 | GO:0048488 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.1 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.7 | GO:0030198 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.0 | 0.0 | GO:1904063 | negative regulation of calcium ion import(GO:0090281) negative regulation of cation transmembrane transport(GO:1904063) |
0.0 | 0.0 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.0 | 0.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.0 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) venous blood vessel development(GO:0060841) |
0.0 | 0.1 | GO:0051593 | response to folic acid(GO:0051593) |
0.0 | 0.0 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.0 | 0.0 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.1 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.0 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.0 | 0.1 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.0 | GO:0060437 | lung growth(GO:0060437) |
0.0 | 0.1 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.2 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.0 | GO:0001945 | lymph vessel development(GO:0001945) |
0.0 | 0.3 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.2 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.1 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.0 | 0.0 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.0 | 0.1 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.0 | 0.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.0 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.0 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.2 | GO:0051963 | regulation of synapse assembly(GO:0051963) |
0.0 | 0.0 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.0 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.0 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.0 | 0.0 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.0 | 0.0 | GO:0003321 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.0 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.0 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.2 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.2 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.1 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.0 | 0.1 | GO:1904427 | positive regulation of calcium ion transmembrane transport(GO:1904427) |
0.0 | 0.6 | GO:0007612 | learning(GO:0007612) |
0.0 | 0.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.1 | GO:0007625 | grooming behavior(GO:0007625) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.0 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.0 | 0.0 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.0 | 1.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.0 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.1 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.0 | 0.0 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament organization(GO:0031033) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.0 | GO:0016999 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.0 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.0 | 0.1 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.0 | GO:0060013 | righting reflex(GO:0060013) |
0.0 | 0.1 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.0 | 0.1 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.0 | 0.0 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.0 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.0 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.0 | 0.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.0 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.0 | 0.1 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 0.0 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.0 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.0 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.0 | 0.1 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.2 | GO:0006309 | DNA catabolic process, endonucleolytic(GO:0000737) apoptotic DNA fragmentation(GO:0006309) |
0.0 | 0.0 | GO:0072109 | renal system vasculature development(GO:0061437) kidney vasculature development(GO:0061440) glomerulus vasculature development(GO:0072012) glomerular mesangium development(GO:0072109) |
0.0 | 0.1 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.0 | 0.0 | GO:0060438 | trachea development(GO:0060438) |
0.0 | 0.0 | GO:0006273 | lagging strand elongation(GO:0006273) DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.0 | 0.0 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.1 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.0 | 0.0 | GO:0051588 | regulation of neurotransmitter transport(GO:0051588) |
0.0 | 0.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.0 | GO:0000042 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.0 | 0.1 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.0 | 0.1 | GO:0031269 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.0 | GO:0055117 | regulation of cardiac muscle contraction(GO:0055117) |
0.0 | 0.0 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 0.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.0 | GO:0003157 | endocardium development(GO:0003157) endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
0.0 | 0.0 | GO:0080111 | DNA demethylation(GO:0080111) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.9 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.2 | 1.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.4 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 1.0 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.2 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.3 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.3 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.0 | 0.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 0.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.2 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.3 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.1 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.0 | 0.4 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.4 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.9 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.2 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 0.5 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.3 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.1 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.3 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.1 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 0.1 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.6 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.1 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.2 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.1 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 1.3 | GO:0030016 | myofibril(GO:0030016) |
0.0 | 0.3 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.5 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.8 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 1.2 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.1 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.4 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.1 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.0 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 2.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.9 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.7 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.0 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 0.1 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.3 | GO:0005912 | adherens junction(GO:0005912) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.7 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.1 | 0.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.4 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.1 | 0.5 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.8 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.3 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 0.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 2.7 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.4 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.3 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.1 | 0.2 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.1 | 0.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.4 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.4 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.1 | 0.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.3 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 0.0 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.4 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.4 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.2 | GO:0031545 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.2 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.2 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.2 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.1 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.2 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.0 | 0.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.2 | GO:0001077 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.1 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.2 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.1 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.1 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.1 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.1 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.1 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.2 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.5 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.0 | 0.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.0 | 0.2 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.0 | 0.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.2 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.1 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.0 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.1 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.1 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.1 | GO:0043734 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.1 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.1 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 0.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.3 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.2 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.0 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.0 | 1.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.0 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.1 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.1 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.0 | 0.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.1 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.0 | 0.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.0 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.1 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.0 | 0.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.0 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.0 | GO:0032558 | purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) |
0.0 | 0.0 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.0 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.0 | 0.1 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.0 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.9 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.0 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.1 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.0 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.1 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.0 | 0.0 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.0 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.0 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.1 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.0 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.0 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.0 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 2.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.0 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 2.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.1 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.1 | PID AURORA A PATHWAY | Aurora A signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.8 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.7 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 1.6 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 2.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.4 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 1.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.0 | 0.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.0 | 0.0 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.0 | 0.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.4 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.0 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.0 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.2 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.0 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.1 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 0.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |